Faculty Opinions recommendation of Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

Ralf Weiskirchen

doi:10.3410/f.727572862.793547475

Hakkımızda SSS Gizlilik Şartlar İletişim

Faculty Opinions recommendation of Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. — Ralf Weiskirchen | RDL Network

Back

Home
Publications
Faculty Opinions recommendation of Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

Shared by

Ralf Weiskirchen

Faculty Opinions recommendation of Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

Dataset en

Authors

RW
Ralf Weiskirchen

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.3410/f.727572862.793547475
Year
Published: —
Language: en

Dataset Details

Link Of The Paper: https://doi.org/10.3410/f.727572862.793547475

Timeline

Created:June 19, 2026

Related publications

Dataset

Faculty Opinions recommendation of Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis.

Ralf Weiskirchen

Dataset

Faculty Opinions recommendation of Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Ralf Weiskirchen

Dataset

Faculty Opinions recommendation of Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.

Ralf Weiskirchen

Dataset

Faculty Opinions recommendation of Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Ralf Weiskirchen

Dataset

Faculty Opinions recommendation of Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).

Ralf Weiskirchen